Blocking nerve cells could prevent symptoms of eczema

October 3, 2013
The itch and inflammation of eczema may be prevented by itch-receptor blockers, based on new research linking the nervous system and the immune system. Credit: Diana Bautista, UC Berkeley

A new picture of how the nervous system interacts with the immune system to cause the itch and inflammation associated with eczema, a chronic skin disease, could lead to new therapies for the condition, according to University of California, Berkeley, scientists.

Some 10 percent of the population suffers from , or atopic dermatitis, at some point in their lives, but there are no cures or even good treatments for it. Symptoms range from dry, flaky and itchy skin to flaming red rashes, and in severe cases, particularly in children, the disease often progresses to nasal allergies and asthma.

Eczema's cause is unknown, but most research today focuses on the immune system's role in reacting to chemicals that cause itching and inflammation. UC Berkeley neuroscientist Diana M. Bautista and graduate students Sarah R. Wilson and Lydia Thé, however, discovered that sensory nerves in the skin are the first to react to these chemicals, and that blocking the skin's itch receptors not only stops the scratching, but may head off the worst consequences of eczema.

"Most drug development has focused on trying to find a way to inhibit the immune response," said Bautista, assistant professor of molecular and cell biology and a member of the Helen Wills Neuroscience Institute. "Now that we have found that sensory neurons may be the first responders, that changes how we think about the disease."

"By just blocking what is happening in the neurons, you could block the symptoms of chronic itch, including the big immune response leading to asthma and allergy," Wilson added. "And you prevent the patient from scratching, which damages skin cells and makes them release more chemicals that cause inflammation and help maintain chronic itch."

The researchers already have identified a potential drug, now in Phase 1 clinical trials for a different inflammatory disease, that stops mice from scratching when it is applied to the skin.

Their new model of eczema is based on findings reported online today (Thursday, Oct. 3) in the journal Cell by Bautista, Wilson, Thé and their UC Berkeley colleagues.

Block that wasabi

"We started out looking at acute itch and asked the question, 'Why do we scratch? Why do we have that urge, and how does it work that scratching gives you some relief, when normally it feels terrible if you don't have an itch and scratch yourself that hard?'" Bautista said. "But the many types of chronic itch that humans experience are all very different. We believe that, through identifying molecular mechanisms, we can find new treatments and therapies for these diseases."

Immunologists several years ago identified a chemical – TSLP (thymic stromal lymphopoietin), a so-called cytokine – that induces itch when expressed in the skin. Because have receptors for this chemical, TSLP triggers them to release chemicals that attract other immune cells and to create the red, itchy inflammation typical of eczema. These inflammatory chemicals seem to spread through the body and induce inflammation in the lungs, gut and nasal passages that lead to asthma and allergies, Bautista said.

Wilson and Bautista, however, focused on what causes the immediate or acute itch. Probing itch-sensitive neurons in the skin, they found that these neurons also have receptors for TSLP, and that TSLP makes these neurons, like immune cells, release chemical mediators that cause inflammation. Furthermore, by looking at human skin cells (keratinocytes) in culture, they discovered the triggers that make skin cells release TSLP in the first place.

"Our hypothesis is that release TSLP, which triggers neurons to release mediators that lead to more inflammation and recruitment of immune cells," helping to set up chronic , Bautista said.

"These itch-sensitive neurons are a small population," she added. "If we could just block the 2 percent of that respond to TSLP, we could have a really selective drug that treats chronic itch, but keeps all of the important functions of skin – normal pain function, normal temperature and tactile sensations – and the many parts of the immune system intact."

Interestingly, the TSLP receptor works through an ion channel, TRPA1, that Bautista discovered when she was a post-doctoral researcher. The channel was named the wasabi ion channel because it is sensitive to "mustard compounds" like those found in Dijon or wasabi. Blockers of the wasabi channel thus would block the action of TSLP and stop itch.

Alternatively, Wilson said, drug developers could look for chemicals that block the release of TSLP from damaged cells.

Bautista and her colleagues are continuing to explore the relative contributions of different types of nerve and immune cells to atopic dermatitis and chronic itch and are developing mouse models in which to test their hypotheses.

Explore further: These scientists are 'itching' to help you stop scratching

Related Stories

These scientists are 'itching' to help you stop scratching

June 5, 2013
Itch and scratch, itch and scratch. It's not the most serious physical problem in our lives, but it is common and it is very annoying. Now, researchers at the Hebrew University of Jerusalem and in Boston have come up with ...

Pain and itch connected down deep

May 2, 2011
A new study of itch adds to growing evidence that the chemical signals that make us want to scratch are the same signals that make us wince in pain.

Scratching the surface: why skin allergies make us itch

June 6, 2013
A Yale-led team of researchers has identified the protein that controls inflammation and the urge to itch in people who suffer from contact dermatitis due to exposure to poison ivy and other allergens. The study appears in ...

Stopping the itch—new clues into how to treat eczema

October 11, 2012
More than 15% of children suffer with eczema, or atopic dermatitis, an inflammatory skin disease that in some cases can be debilitating and disfiguring. Researchers reporting in the October issue of Immunity have discovered ...

Body location plays part in scratching pleasure

January 27, 2012
An itch is just an itch. Or is it? New research from Gil Yosipovitch, M.D., Ph.D., professor of dermatology at Wake Forest Baptist Medical Center and a world-renowned itch expert, shows that how good scratching an itch feels ...

Itching can have a visual trigger, new research reveals

November 25, 2012
(Medical Xpress)—Itching is so contagious that simply seeing an image of an itch stimulus – such as ants or an insect bite – can trigger a physical response, new research suggests.

Recommended for you

Want to win at sports? Take a cue from these mighty mice

July 20, 2017
As student athletes hit training fields this summer to gain the competitive edge, a new study shows how the experiences of a tiny mouse can put them on the path to winning.

'Smart' robot technology could give stroke rehab a boost

July 19, 2017
Scientists say they have developed a "smart" robotic harness that might make it easier for people to learn to walk again after a stroke or spinal cord injury.

Engineered liver tissue expands after transplant

July 19, 2017
Many diseases, including cirrhosis and hepatitis, can lead to liver failure. More than 17,000 Americans suffering from these diseases are now waiting for liver transplants, but significantly fewer livers are available.

Lunatic Fringe gene plays key role in the renewable brain

July 19, 2017
The discovery that the brain can generate new cells - about 700 new neurons each day - has triggered investigations to uncover how this process is regulated. Researchers at Baylor College of Medicine and Jan and Dan Duncan ...

New animal models for hepatitis C could pave the way for a vaccine

July 19, 2017
They say that an ounce of prevention is worth a pound of cure. In the case of hepatitis C—a disease that affects nearly 71 million people worldwide, causing cirrhosis and liver cancer if left untreated—it might be worth ...

Omega-3 fatty acids fight inflammation via cannabinoids

July 18, 2017
Chemical compounds called cannabinoids are found in marijuana and also are produced naturally in the body from omega-3 fatty acids. A well-known cannabinoid in marijuana, tetrahydrocannabinol, is responsible for some of its ...

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

packrat
1 / 5 (1) Oct 03, 2013
Wasn't there an article on here not too long ago that said they had found Eczema is caused by the bacteria in crap from skin mites?

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.